Agilent Technologies, Inc.

A Medical devices

Makes instruments and reagents for cancer diagnostics and life sciences research.

Jul 2026Revenue $7.37B/yrExpenses $5.73B/yr
No trend
Figures by year

Is Agilent Technologies profitable?

Yes. In the 12 months to Jul 2026, revenue was $7.37B and expenses $5.73B.

Fiscal year toRevenueExpensesOperating profit
Oct 2025$6.95B$5.47B$1.48B
Oct 2024$6.51B$5.02B$1.49B
Oct 2023$6.83B$5.48B$1.35B
Oct 2022$6.85B$5.23B$1.62B
Oct 2021$6.32B$4.97B$1.35B
Oct 2020$5.34B$4.49B$846M
Oct 2019$5.16B$4.22B$941M
Oct 2018$4.91B$4.01B$904M
Oct 2017$4.47B$3.67B$807M
Oct 2016$4.20B$3.59B$615M